Clinical Trial Update: A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 first-in-human study evaluating safety, tolerability, and pharmacology of PF-06826647 in healthy subjects and patients with plaque psoriasis has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• PF-06826647

Snippet

Sponsor: Pfizer | Conditions: Plaque Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2020-03-31